What is ALXO's dilution risk score?

ALXO has a latest available DilutionScore record of 38/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for ALXO, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for ALXO?

DilutionWatch tracks 25 SEC filing types for ALXO including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect ALXO shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For ALXO, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for ALXO tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for ALXO. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

ALXO Dilution Risk Score: 38/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

50

💰 Cash Runway

40

📊 Float Risk

17

⚠️ Warrant Exposure

15

🔄 Convertible Debt

40

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 20%

🔄 Reverse Split model est. 30%

• 50-day avg $1.89 approaching $1 threshold

💰 Capital Raise model 18%

• Active ATM program with $118M remaining capacity

🔔 Track ALXO — Get forecast alerts →

Market Data

Market Cap$255.67M

Shares Outstanding138.28M

Float107.02M

Cash$138.23M

Debt$9.71M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 241.4% shares (2026Q1 vs prior)

72 institutional holders · 102.44M shares

#1 RA CAPITAL MANAGEMENT, L.P. 13.01M shares

#2 TCG Crossover Management, LLC 13.01M shares

#3 venBio Partners LLC 12.88M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest7.72M

Days to Cover13.3

% of Float7.2%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

xbrl XBRL CONVERTIBLE 2020-12-31

4 INSIDER TRANSACTION 2026-04-17

3 FORM3 2026-04-17

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual ALXO Dilution Snapshot

ALX Oncology Holdings Inc. (ALXO) has a DilutionScore of 38/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored ATM program remaining capacity: $117.8M.
Recent SEC activity tracked for ALXO: xbrl on 2026-06-30; 4 on 2026-04-17; 4 on 2026-04-17.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.